- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 412745, 6 pages
The Study on Biocompatibility of Porous nHA/PLGA Composite Scaffolds for Tissue Engineering with Rabbit Chondrocytes In Vitro
1Guangzhou Medical College, Guangzhou, Guangdong 510182, China
2Department of Orthopedics, Second People’s Hospital of Shenzhen, Sungang West Road, Futian District, Shenzhen, Guangdong 518035, China
3Shenzhen Key Laboratory of Tissue Engineering, Shenzhen, Guangdong 518035, China
4Biomechanics and Medical Information Institute, Beijing University of Technology, Beijing 100022, China
Received 6 July 2013; Revised 4 September 2013; Accepted 4 September 2013
Academic Editor: Aaron W. James
Copyright © 2013 Lei Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Objective. To examine the biocompatibility of a novel nanohydroxyapatite/poly[lactic-co-glycolic acid] (nHA/PLGA) composite and evaluate its feasibility as a scaffold for cartilage tissue engineering. Methods. Chondrocytes of fetal rabbit were cultured with nHA/PLGA scaffold in vitro and the cell viability was assessed by MTT assay first. Cells adhering to nHA/PLGA scaffold were then observed by inverted microscope and scanning electron microscope (SEM). The cell cycle profile was analyzed by flow cytometry. Results. The viability of the chondrocytes on the scaffold was not affected by nHA/PLGA comparing with the control group as it was shown by MTT assay. Cells on the surface and in the pores of the scaffold increased in a time-dependent manner. Results obtained from flow cytometry showed that there was no significant difference in cell cycle profiles between the coculture group and control (). Conclusion. The porous nHA/PLGA composite scaffold is a biocompatible and good kind of scaffold for cartilage tissue engineering.
Large-area cartilage defect has been difficult to treat in orthopedics for years. There are a number of ways to repair cartilage defect at present, such as cartilage graft repair, perichondrium or periosteum graft repair, and autologous or allogeneic chondrocytes graft repair. However, tissue engineering is one of the hot spots and the most promising method among others, which integrates seed cells, scaffolds, and the construction of tissue-engineered bone. Many scholars have been seeking suitable biomaterials for cartilage tissue engineering and conceived various composite materials as scaffold. Xia and his colleagues  investigated whether man-made porous chitosan-gelatin complex scaffold was suitable for cartilage tissue engineering in 2003. However, in most researches, cell division, proliferation, and migration have not been considered, and the effects of material degradation on cell activity have also not been investigated. Here, we introduce a new type of porous composite scaffold, nano-hydroxyapatite/poly[lactic-co-glycolic acid] (nHA/PLGA) and explore its biocompatibility with rabbit chondrocytes through in vitro coculture experiments.
2. Materials and Methods
2.1. Main Experimental Materials, Reagents, and Equipment
Dulbecco’s Modified Eagle Medium (DMEM) (BioWhittaker, Verviers, Belgium); 20% fetal bovine serum (FBS), TRIzol Reagent, and AnnexinV-FITC/PI (Invitrogen, USA); Percoll separation solution, trypsin, penicillin, and streptomycin (Gibco, USA); MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium (KeyGEN, Nanjing, China)); high pressure sterilizer MLS-3780 (SANYO, Japan); clean bench VS-840 (Suzhou, China), ELIASA Model 1680 (Bio-Rad, USA); fluorescence microscopy (Leica, Germany), MIKRO 22R (Hettich, Germany); and flow cytometry (Beckman/Coulter,USA) and scanning electron microscope (TESCAN, Czech) were used in the present study.
2.2. Preparation of Porous nHA/PLGA Scaffolds
Low temperature rapid prototyping technology  was used to prepare the three-dimensional porous PLGA/n-HA composite. One representative PLGA/n-HA composite sample was shown in Figure 1. The sample was porous and could be cut to proper size for the coculture experiment.
2.3. Isolation and Culture of Primary Chondrocytes from Fetal Rabbit Articular Cartilage
Three fetal rabbits born within 10 days were provided by the Medical Laboratory Animal Center of the Guangdong Province for the study. The rabbits were anesthetized to death and the cartilages were cut and rinsed with PBS plus penicillin and streptomycin (Gibco, USA) for 3 times. The surrounding connective tissues and vessels were removed and the cartilages were cut to 1 cubic millimeter. The tissues were digested with 0.25% trypsin (Gibco, USA) at 37°C for 30 min followed by the digestion with 0.2% collagenase II (Gibco, USA) for 6 h with shaking. Cells were collected after filtration and centrifugation and resuspended with DMEM/F12 (BioWhittaker, Verviers, Belgium) plus 10% FBS (Gibco, USA) and seeded at 1 × 105 per mL in flasks. Media were refreshed every 3 days and cells were passaged when the confluence reached 80%. The third passage of chondrocytes was used for the co-culture experiment.
2.4. Coculture of Rabbit Chondrocytes and Porous nHA/PLGA Scaffold
The experiment employed control group and experimental group. For control group (group A), chondrocytes were seeded in 24-well plate alone. As for experimental group (group B), namely, coculture of cells and the scaffold, nHA/PLGA scaffolds were immersed in PBS for 5 min first and then placed in 24-well plate. Chondrocytes were then seeded at 5 × 105 per well. All the plates were placed in the 37°C incubator supplied with 5% CO2. The media were refreshed every 3 days.
2.5. Cell Viability Assay
MTT assay was used to test the cell viability. Cells on day 1, day 3, day 5, day 7, and day 9 were used for the assay. 50 μL MTT (KeyGEN, Nanjing, China) was added per well and incubated at 37°C for 2 h. The media were carefully removed and 200 μL DMSO (Gibco, USA) was added into each well. The absorbances were measured at 490 nm using a microplate reader (BioTek, Winooski, USA).
2.6. Imaging and Image Analysis
A microscope (Leica, Germany) was used to observe the cells of group A and group B on day 1, day 3, and day 5. Scanning electron microscopy (SEM) was used to characterize the cell morphology on the biphasic composite. The scaffolds were fixed with glutaraldehyde, dehydrated with gradient alcohol, and dried. The scaffolds were then sputter-coated with gold and imaged using an SEM (TESCAN, Czech).
2.7. Flow Cytometry Analysis
Cells in both groups were collected after 7 days in culture for cell cycle analysis. Cell cycles were tested using a flow cytometer (Beckman/Coulter, USA) and the profiles were obtained by flow cytometry analysis. Proliferation index (PI) was calculated and studied by statistical analysis. .
2.8. Statistical Analysis
Statistical analysis was performed by SPSS 17.0 with significance determined at . Results are reported as mean ± standard error.
3.1. Parameters of the Scaffold
The porous nHA/PLGA composite Scaffold is 20 mm × 20 mm × 20 mm (Figure 1) in size. The porosity was measured by alcohol soaking method and average porosity was 85%~90%. The pore size of the scaffold was measured by scanning electron microscopy (Sem), ranging from 100 to 300 microns (Figure 2(b)).
3.2. MTT Assay
The cell viabilities were determined by MTT assay. As it was shown in Figure 3, no significance was observed between group A and group B () with regard to cell proliferation capability.
3.3. Microscopy Observation
Chondrocytes in group A and group B were imaged and analyzed by inverted microscope (Figures 4(a)–4(f)). In both groups, the chondrocytes were observed triangle-shaped, disc-shaped, and megagon-shaped. The cells were connected by cellular processes. The chondrocytes observed kept proliferating and differentiating during culture.
3.4. Scanning Electron Microscopy (SEM)
The images of chondrocytes grown on the scaffold were shown in Figure 5. Chondrocytes on the scaffold showed good extension capability and were fusiform-shaped. The cells increased in a time-dependent manner and gradually fused.
3.5. Cell Cycle Profiles
After 7 days in co-culture, chondrocytes in both groups were in normal shape and no abnormal diploid cell was observed. nHA/PLGA scaffold had little influence on cell growth. As it was shown in Table 1, no significance was observed between the two groups ().
Tissue engineering has been the focus of research for long bone and cartilage defect repair in recent years. As the scaffolds are very important for tissue engineering, biocompatibility test must be carried out before use. Biocompatibility test mainly includes cell viability test, cell proliferation, and growth test on the materials . Chondrocytes have been used as the seed cells for tissue engineering [4, 5]; however, dedifferentiation of chondrocytes cultured in vitro limited the use of passaged chondrocytes for tissue engineering . Liu and his colleagues found that chondrocytes could grow well within three generations and maintain stable biological characters in vitro . Therefore, chondrocytes of fetal rabbit limb joints within three generations were used in this experiment.
4.2. Preparation and Characteristics of nHA/PLGA Scaffolds
Hydroxyapatite (HA) is the most common type of bioactive materials. It is one of the inorganic compositions of human bone tissue and has good biocompatibility and bone conductibility . In recent years, nanohydroxyapatite material began to be widely used in the field of tissue engineering , especially when it is mixed with organic compound to generate composite scaffold . Polylactic-co-glycolic acid (PLGA) is currently the most used scaffold in tissue engineering, as it has good biocompatibility and controllable biodegradability. Moreover, the degraded products can be metabolized [11–13]. The nHA/PLGA scaffold material of this research is different from any other single material. It is composed of nHA and PLGA via computer-aided rapid prototyping technology and freeze-drying compound. Thus, it has the characteristics of the two kinds of materials. (1) It is more advantageous for extracellular matrix protein adhesion and interaction due to the nanostructure of material . It is able to guide tissue cells to grow , and the biodegradability increases as the result of the increase of surface area . (2) It can meet the mechanical strength of implant materials because of its higher toughness. (3) PLGA degradation products can be neutralized to some extent by nHA, thus preventing the aseptic inflammation effectively. It can also accelerate the degradation of the scaffold. (4) Its composition, shape, microstructure, and mechanical properties can be predicted in advance and it can be made to meet the clinical needs in the process of scaffold production. If porous nHA/PLGA composites with different nHA/PLGA ratios can be synthesized and different biomechanical scaffolds can be produced, not only cartilage defects but also large weight-bearing bone defect might be repaired. Li used nHA/CS composite with chondrocytes to repair rabbit articular cartilage and subchondral bone defect with good outcomes .
In addition, a good scaffold should have not only good biocompatibility, but also proper pore size and porosity . Studies show that 200 to 350 microns are suitable for cell invasion  and is conductive to cell growth. For nano fiber mesh connection, it could promote infiltration of oxygen and nutrition of the body fluid inside the scaffold, which is vital to the successful repair of defects. The pore size of our nHA/PLGA porous scaffold is about 100–300 microns and the porosity is of 85%~90%, which is in full compliance with all kinds of cells.
The interaction of scaffold and microenvironment cannot be explored in this experiment, as chondrocytes and scaffold were cocultured in vitro. In vitro culture system cannot completely simulate biological environment in the body, so animal experiments are needed for further in vivo verification. In addition, as more and more new types and suitable tissue engineering scaffolds arise for clinical applications and with the progress of the scaffold technology, tissue engineering may eventually benefit the patients.
The present study investigated the feasibility of nHA/PLGA being a biocompatible scaffold by cell viability test, microscope and SEM observation, and flow cytometry analysis of the cell cycle. MTT assay tested cell activity, which showed the scaffold itself had no effect on cartilage cell proliferation. Inverted microscope and SEM observation showed cell morphology at different periods of culture. With the extension of incubation time, the chondrocytes could normally adhere to the stent surface and rapidly proliferate. Flow cytometry analysis found that the scaffold had no effect on cell cycle. No abnormal diploid cell was found; thus, the scaffold materials have no tumorigenicity. In general, the nHA/PLGA porous scaffolds used in this experimental study have no adverse effects on cartilage cell adhesion, growth, proliferation, and differentiation. Therefore, the nHA/PLGA porous scaffold is with good cell compatibility and a good kind of cartilage tissue engineering scaffold.
This study received financial support from the Shenzhen Science and Technology R & D project planning (Project no. is CXZZ20130321152713220), the Guangdong Province Medical Research Fund (Project no. is B2012320), the Guangdong Province Outstanding Youth Innovative Talent Training Program (Seedling project; the Project no. is 2012LYM_0120), and the Emerging Scientist Project of Shenzhen Second People’s Hospital.
- W.-Y. Xia, W. Liu, L. Cui et al., “The experimental study of tissue engineered autologous cartilage using chitosan-gelatin complex scaffolds,” Chinese Medical Journal, vol. 83, no. 7, pp. 577–579, 2003.
- C. Lei, F. Zhi-qiang, L. Zhi-yong, et al., “The Research progress of nHA/PLGA composite artificial bone materials,” Journal of Hubei Medical University, vol. 31, no. 4, pp. 347–350, 2012.
- C. Wang, G. Meng, L. Zhang, Z. Xiong, and J. Liu, “Physical properties and biocompatibility of a core-sheath structure composite scaffold for bone tissue engineering in vitro,” Journal of Biomedicine and Biotechnology, vol. 2012, Article ID 579141, 9 pages, 2012.
- N. D. Hsieh-Bonassera, I. Wu, J. K. Lin et al., “Expansion and redifferentiation of chondrocytes from osteoarthritic cartilage: cells for human cartilage tissue engineering,” Tissue Engineering A, vol. 15, no. 11, pp. 3513–3523, 2009.
- H. Masukawa, Y. Miura, I. Sato, Y. Oiso, and A. Suzuki, “Enhanced cartilage tissue engineering by sequential exposure of chondrocytes to FGF-2 during 2D expansion and BMP-2 during 3D cultivation,” Journal of Cellular Biochemistry, vol. 83, no. 1, pp. 121–128, 2001.
- A. Rodrigues, S. Pap, C. A. Vacanti, et al., “The effect of long-term culture on the ability of human auricular chondrocytes to generate tissue engineered cartilage,” in Biological Matrices and Tissue Reconstruction, G. B. Stard, R. Horch, and E. Tanczos, Eds., pp. 163–1168, Springer, New York, NY, USA, 1998.
- L. Wu, Z. Xiao-rong, G. Li, et al., “Isolation, culture and identification of New Zealand rabbit articular cartilage cells,” International Journal of Laboratory Medicine, vol. 33, no. 19, pp. 2307–2312, 2012.
- M. Vallet-Regí, I. Izquierdo-Barba, and M. Colilla, “Structure and functionalization of mesoporous bioceramics for bone tissue regeneration and local drug delivery,” Philosophical Transactions of the Royal Society A, vol. 370, no. 1963, pp. 1400–1421, 2012.
- N. M. Hu, Z. Chen, X. Liu, et al., “Mechanical properties and in vitro bioactivity of injectable and self-setting calcium sulfate/nano-HA/collagen bone graft substitute,” Journal of the Mechanical Behavior of Biomedical Materials, vol. 12, pp. 119–1128, 2012.
- C. Qi, W. Da-ping, L. Jian-quan, et al., “Preparation and biocompatibility study of nano-hydroxyapatite/polyaiticglycolic acid composite material,” International Journal of Orthopaedics, vol. 31, no. 6, pp. 349–351, 2010.
- M. Mueller, W. Reichardt, J. Koerner, et al., “Coencapsulation of tumor lysate and CpG-ODN in PLGA-microspheres enables successful immunotherapy of prostate carcinoma in TRAMP mice,” Control Release, vol. 162, no. 1, pp. 159–166, 2012.
- A. Mittal, R. Kumar, D. Parsad, et al., “Cytomodulin-functionalized porous PLGA particulate scaffolds respond better to cell migration, actin production and wound healing in rodent model,” Tissue Engineering and Regenerative Medicine, 2012.
- S. Piao, I. G. Kim, J. Y. Lee, et al., “Therapeutic effect of adipose-derived stem cells and BDNF-immobilized PLGA membrane in a rat model of cavernous nerve injury,” The Journal of Sexual Medicine, vol. 9, no. 8, pp. 1968–1979, 2012.
- O. Im, J. Li, M. Wang, et al., “Biomimetic three-dimensional nanocrystalline hydroxyapatite and magnetically synthesized single-walled carbon nanotube chitosan nanocomposite for bone regeneration,” International Journal of Nanomedicine, vol. 7, pp. 2087–2099, 2012.
- K. M. Woo, V. J. Chen, and P. X. Ma, “Nano-fibrous scaffolding architecture selectively enhances protein adsorption contributing to cell attachment,” Journal of Biomedical Materials Research A, vol. 67, no. 2, pp. 531–537, 2003.
- V. J. Chen and P. X. Ma, “The effect of surface area on the degradation rate of nano-fibrous poly(l-lactic acid) foams,” Biomaterials, vol. 27, no. 20, pp. 3708–3715, 2006.
- L. Song-wei, Z. Jie-ruo, H. Zhen-gang, et al., “Repairing osteochondral defect of rabbits with Nano-HA/CS scaffold composite with chondrocyte by boot-shaped structure,” Journal of Sun Yat-Sen University, vol. 33, no. 3, pp. 282–286, 2012.
- R. G. Flemming, C. J. Murphy, G. A. Abrams, S. L. Goodman, and P. F. Nealey, “Effects of synthetic micro- and nano-structured surfaces on cell behavior,” Biomaterials, vol. 20, no. 6, pp. 573–588, 1999.
- W. Zhu, J. Xiao, D. Wang et al., “Experimental study of nano-HA artificial bone with different pore sizes for repairing the radial defect,” International Orthopaedics, vol. 33, no. 2, pp. 567–571, 2009.